OTCMKTS:TSMRF Tsumura & Co. (TSMRF) Stock Price, News & Analysis $23.20 0.00 (0.00%) As of 09/3/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartNews and Trends About Tsumura & Co. Stock (OTCMKTS:TSMRF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Tsumura & Co. alerts:Sign Up Key Stats Today's Range$23.20▼$23.2050-Day Range$23.20▼$23.2052-Week Range$23.20▼$25.75VolumeN/AAverage Volume400 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Tsumura & Co. is a Tokyo‐based pharmaceutical company specializing in the research, development and manufacture of Kampo medicines, which are traditional Japanese herbal remedies rooted in Chinese materia medica. The company’s core business revolves around the extraction, standardization and quality control of crude herbal ingredients, transforming them into prescription‐grade and over‐the‐counter products that are approved under Japan’s national health insurance system. Leveraging a combination of modern analytical technology and traditional knowledge, Tsumura produces a broad portfolio of Kampo formulations for a range of therapeutic applications, including gastrointestinal health, circulatory support and immune regulation. In addition to its prescription products, the company offers dietary supplements and health‐oriented items designed to meet consumer demand for natural wellness solutions. While Tsumura’s primary market remains Japan, the company has expanded its reach through overseas subsidiaries and partnerships, notably in the United States and China, where it promotes both research collaborations and product distribution. Throughout its history, Tsumura has emphasized scientific validation of herbal efficacy, investing in clinical trials and collaborative research with academic institutions to bolster the credibility of Kampo medicine in international markets.AI Generated. May Contain Errors. Read More Receive TSMRF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tsumura & Co. and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TSMRF Stock News HeadlinesTsumura Takes Yomeishu Seizo Private to Boost OTC and Preventive HealthcareSeptember 1, 2026 | tipranks.comTsumura Appoints COO Kei Sugii as Additional Representative Director to Bolster ManagementJune 25, 2026 | tipranks.comA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.September 5 at 1:00 AM | Porter & Company (Ad)Tsumura to Take Yomeishu Private in ¥6.8 Billion Multi-Stage Deal to Expand Healthcare PortfolioFebruary 24, 2026 | tipranks.comTsumura Aligns Yomeishu Share Acquisition With Long-Term Kampo Healthcare VisionFebruary 24, 2026 | tipranks.comTsumura Updates Q3 FY2026 Results and Expands Consolidation of Chinese Herbal SubsidiaryFebruary 5, 2026 | tipranks.comTsumura Confirms It Is Weighing Reported Yomeishu Take-Private but Says No Decision YetFebruary 2, 2026 | tipranks.comTsumura Secures ¥50 Billion Syndicated Loan with Financial Covenants for Growth InvestmentJanuary 15, 2026 | tipranks.comSee More Headlines TSMRF Stock Analysis - Frequently Asked Questions How have TSMRF shares performed this year? Tsumura & Co.'s stock was trading at $23.20 at the beginning of 2026. Since then, TSMRF shares have increased by 0.0% and is now trading at $23.20. How do I buy shares of Tsumura & Co.? Shares of TSMRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/04/2026Next Earnings (Estimated)11/09/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:TSMRF CIKN/A Webwww.tsumura.co.jp Phone81 3 6361 7101FaxN/AEmployees4,032Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:TSMRF) was last updated on 9/5/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tsumura & Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tsumura & Co. With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
